{"title":"HD Labs","description":null,"products":[{"product_id":"hd-labs-retatrutide-32mg-vial","title":"HD Labs Retatrutide 32mg Vial","description":"\u003ch1\u003e\u003cstrong\u003eRetatrutide: Triple-Action Metabolic Support\u003c\/strong\u003e\u003c\/h1\u003e\n\u003ch2\u003e\u003cstrong\u003eWhat is Retatrutide?\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003eRetatrutide is a powerful investigational drug designed for weight loss and blood sugar control. It activates three key hormone receptors.\u003c\/p\u003e\n\u003ch2\u003e\u003cstrong\u003eHow It Works\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eStimulates\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eGLP-1, GIP, and glucagon\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003ereceptors.\u003c\/li\u003e\n\u003cli\u003eSuppresses appetite and boosts metabolism.\u003c\/li\u003e\n\u003cli\u003eEnhances insulin release for better blood sugar control.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cstrong\u003eWhy Use Retatrutide?\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eSupports\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003erapid and sustained weight loss\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eImproves\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003einsulin sensitivity and glucose regulation\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eIncreases\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003efat burning and energy balance\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003e\u003cstrong\u003eBenefits\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cp\u003e✔ Reduces hunger and calorie intake.\u003cbr\u003e✔ Improves\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eblood sugar stability\u003c\/strong\u003e.\u003cbr\u003e✔ Enhances\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003efat metabolism\u003c\/strong\u003e.\u003cbr\u003e✔ Supports\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003elong-term weight management\u003c\/strong\u003e.\u003c\/p\u003e\n\u003ch2\u003e\u003cstrong\u003eRecommended Dosage\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStart with a low dose\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eand increase gradually.\u003c\/li\u003e\n\u003cli\u003eTypical use is\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003ea once-weekly injection\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eAlways\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003efollow medical guidance\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003efor safe use.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eRetatrutide is a promising new treatment for obesity and metabolic disorders. Consult a doctor before use.\u003c\/p\u003e","brand":"Mari's Studio","offers":[{"title":"Default Title","offer_id":49337200181387,"sku":null,"price":1700.0,"currency_code":"ZAR","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0765\/1390\/2731\/files\/24e2d5a8-6397-4d89-896f-ac98df4f36ab-HD-reta-self-mix.jpg?v=1789032944"},{"product_id":"hd-labs-retatrutide-pen","title":"HD Labs Retatrutide 32mg Pen","description":"\u003cp\u003eRetatrutide is a peptide currently under advanced clinical investigation for its activity across multiple metabolic pathways. It is designed to act on\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003ethree key receptors involved in glucose and energy regulation\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eGLP-1 (glucagon-like peptide-1)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eGIP (glucose-dependent insulinotropic polypeptide)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eGlucagon receptors\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThrough this\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003etriple-agonist mechanism\u003c\/strong\u003e, retatrutide has been studied for its effects on insulin secretion, regulation of glucose production, gastric emptying, and appetite-related signalling.\u003c\/p\u003e\n\u003chr\u003e\n\u003ch3\u003eClinical Trial Status\u003c\/h3\u003e\n\u003cp\u003eAs of\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003e2025\u003c\/strong\u003e, retatrutide remains\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eunder investigation and is not yet formally approved\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003efor general medical use.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePhase 2 clinical studies\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003ereported significant outcomes, with participants experiencing an\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eaverage body-weight reduction of approximately 24.2% over 48 weeks\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eunder controlled trial conditions.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePhase 3 clinical trials\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eare ongoing and have reported\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003econtinued, clinically meaningful effects consistent with earlier trial phases\u003c\/strong\u003e, further evaluating long-term safety, efficacy, and tolerability. Final data and regulatory review are pending.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eNo guarantees of outcome can be inferred outside of controlled clinical settings.\u003c\/p\u003e\n\u003chr\u003e\n\u003ch3\u003eHow Retatrutide Compares\u003c\/h3\u003e\n\u003cp\u003eRetatrutide is often discussed alongside other incretin-based compounds:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eSemaglutide\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eacts primarily as a\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eGLP-1 receptor agonist\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eTirzepatide\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis a\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003edual agonist\u003c\/strong\u003e, targeting both\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eGLP-1 and GIP receptors\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eRetatrutide\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis a\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003etriple agonist\u003c\/strong\u003e, additionally engaging the\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eglucagon receptor\u003c\/strong\u003e, which differentiates its investigational profile from earlier-generation compounds\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr\u003e\n\u003ch3\u003eImportant Information\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eThis product is supplied in a\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003epre-mixed pen format\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eRetatrutide remains an\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003einvestigational compound\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eConsultation with a\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003elicensed healthcare provider\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis essential prior to any consideration of use\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eResults observed in clinical trials may not reflect real-world outcomes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr\u003e\n\u003ch3\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003cp\u003eThis product is supplied strictly on an\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003einformed purchaser basis\u003c\/strong\u003e. By purchasing, you acknowledge that:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eYou have independently researched this product and its investigational status\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eYou have consulted, or will consult, a qualified healthcare professional\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eYou understand that retatrutide is\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003enot yet approved\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eand remains subject to ongoing clinical evaluation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eThe seller provides\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eno medical advice, treatment claims, or dosing guidance\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eThe\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eonus of lawful, safe, and appropriate use rests entirely with the purchaser\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Mari's Studio","offers":[{"title":"Default Title","offer_id":49337223741579,"sku":null,"price":2400.0,"currency_code":"ZAR","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0765\/1390\/2731\/files\/50e9a8a6-eef4-467a-9581-186fbefdaf25-hd-reta-pen.jpg?v=1789034467"},{"product_id":"hd-labs-retatrutide-64mg-vial","title":"HD Labs Retatrutide 64mg Vial","description":"\u003cp\u003eRetatrutide is a peptide currently under advanced clinical investigation for its activity across multiple metabolic pathways. It is designed to act on\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003ethree key receptors involved in glucose and energy regulation\u003c\/strong\u003e:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eGLP-1 (glucagon-like peptide-1)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eGIP (glucose-dependent insulinotropic polypeptide)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eGlucagon receptors\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThrough this\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003etriple-agonist mechanism\u003c\/strong\u003e, retatrutide has been studied for its effects on insulin secretion, regulation of glucose production, gastric emptying, and appetite-related signalling.\u003c\/p\u003e\n\u003chr\u003e\n\u003ch3\u003eClinical Trial Status\u003c\/h3\u003e\n\u003cp\u003eAs of\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003e2025\u003c\/strong\u003e, retatrutide remains\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eunder investigation and is not yet formally approved\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003efor general medical use.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePhase 2 clinical studies\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003ereported significant outcomes, with participants experiencing an\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eaverage body-weight reduction of approximately 24.2% over 48 weeks\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eunder controlled trial conditions.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003ePhase 3 clinical trials\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eare ongoing and have reported\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003econtinued, clinically meaningful effects consistent with earlier trial phases\u003c\/strong\u003e, further evaluating long-term safety, efficacy, and tolerability. Final data and regulatory review are pending.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eNo guarantees of outcome can be inferred outside of controlled clinical settings.\u003c\/p\u003e\n\u003chr\u003e\n\u003ch3\u003eHow Retatrutide Compares\u003c\/h3\u003e\n\u003cp\u003eRetatrutide is often discussed alongside other incretin-based compounds:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eSemaglutide\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eacts primarily as a\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eGLP-1 receptor agonist\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eTirzepatide\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis a\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003edual agonist\u003c\/strong\u003e, targeting both\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eGLP-1 and GIP receptors\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003eRetatrutide\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis a\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003etriple agonist\u003c\/strong\u003e, additionally engaging the\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eglucagon receptor\u003c\/strong\u003e, which differentiates its investigational profile from earlier-generation compounds\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr\u003e\n\u003ch3\u003eImportant Information\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eThis product is supplied in a\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003evial.\u003c\/strong\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eRetatrutide remains an\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003einvestigational compound\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eConsultation with a\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003elicensed healthcare provider\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis essential prior to any consideration of use\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eResults observed in clinical trials may not reflect real-world outcomes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr\u003e\n\u003ch3\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003cp\u003eThis product is supplied strictly on an\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003einformed purchaser basis\u003c\/strong\u003e. By purchasing, you acknowledge that:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003eYou have independently researched this product and its investigational status\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eYou have consulted, or will consult, a qualified healthcare professional\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eYou understand that retatrutide is\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003enot yet approved\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eand remains subject to ongoing clinical evaluation\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eThe seller provides\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eno medical advice, treatment claims, or dosing guidance\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eThe\u003cspan\u003e \u003c\/span\u003e\u003cstrong\u003eonus of lawful, safe, and appropriate use rests entirely with the purchaser\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Mari's Studio","offers":[{"title":"Default Title","offer_id":49337225052299,"sku":null,"price":2500.0,"currency_code":"ZAR","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0765\/1390\/2731\/files\/791056b8-30cc-40ab-b70b-2fecc39439d8-WhatsApp-Image-2026-09-07-at-12.57.39.jpg?v=1789034768"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0765\/1390\/2731\/collections\/hd-labs-black.webp?v=1788955191","url":"https:\/\/studiomari.co.za\/collections\/body-pharm-copy.oembed","provider":"Mari's Studio","version":"1.0","type":"link"}